EUVIMEDEUVIMED entdecken
Crossref

Assessment of blinding in clinical trials

Heejung Bang, Liyun Ni, Clarence E Davis

Controlled Clinical Trials · 2004-04 · 25 (2) · 143-156

DOI: 10.1016/j.cct.2003.10.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Controlled Clinical Trials, 2004-04. Verfasst von Heejung Bang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of North Carolina at Chapel Hill, 137 E. Franklin Street, Chapel Hill, NC 27599, USA. hejung_bang@unc.edu. Hauptthemen laut MEDLINE: Double-Blind Method. Die Arbeit wurde bisher 611-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Double-Blind MethodAgedAnticholesteremic AgentsBiasControlled Clinical Trials as TopicHumansModels, StatisticalReproducibility of ResultsResearch Design

Substanzen

Anticholesteremic Agents

Autor:innen und Institutionen

  • Department of Biostatistics, University of North Carolina at Chapel Hill, 137 E. Franklin Street, Chapel Hill, NC 27599, USA. hejung_bang@unc.edu

Zitieren

APA

Bang, H., Ni, L., & Davis, C. E. (2004). Assessment of blinding in clinical trials. Controlled Clinical Trials, 25(2), 143-156. https://doi.org/10.1016/j.cct.2003.10.016

Vancouver

Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Controlled Clinical Trials. 2004;25(2):143-156. doi:10.1016/j.cct.2003.10.016

BibTeX
@article{Bang2004,
  author = {Bang, Heejung and Ni, Liyun and Davis, Clarence E},
  title = {Assessment of blinding in clinical trials},
  journal = {Controlled Clinical Trials},
  year = {2004},
  volume = {25},
  number = {2},
  pages = {143--156},
  doi = {10.1016/j.cct.2003.10.016}
}
Kostenlos starten →